About

Dr. Kim is a laboratory-based physician-scientist. Clinically, Kim takes care of patients with genitourinary malignancies.

The Kim Laboratory studies the genetics and cancer biology underlying the initiation and progression of bladder and kidney cancers. The Kim Lab uses in vitro methods as well as patient derived xenograft tumors and genetically engineered murine (GEM) models of cancer. Kim co-directs UNC’s Mouse Phase 1 Unit (MP1U) and is involved in the Next Gen sequencing of both human cancer genomes as the interim Director for Precision Oncology for UNC Lineberger.